Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135102) titled 'A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection in Patients With Metastatic Castration-resistant Prostate Cancer' on Aug. 14.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Xiaorong Sun
Condition:
Metastatic Castration-Resistant Prostate Cancer Patients
Intervention:
Drug: 225Ac-PSMA-XT
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: October 14, 2024
Target Sample Size: 40
Countries of Recruit...